Bellicum Pharmaceuticals

+$0.06 (+2.10%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLCM and other ETFs, options, and stocks.

About BLCM

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.

CEO
Richard A. Fair
Employees
16
Headquarters
Houston, Texas
Founded
2004

BLCM Key Statistics

Market Cap
26.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
119.41K
High Today
$2.93
Low Today
$2.82
Open Price
$2.87
Volume
42.14K
52 Week High
$8.19
52 Week Low
$2.57

BLCM Earnings

-$7.81
-$4.83
-$1.84
$1.14
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure